/K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
Advertisement
Journalists and other readers should disregard the news release "OramedPharmaceuticals Launches Phase 1A Trials of its Insulin Suppository"OTC:ORMP, issued earlier today. The release was transmitted in error by PRNewswire.